Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CA19-9: the Italian experience

L Gullo1

  • 1Institute of Medicine and Gastroenterology, University of Bologna, St. Orsola Hospital, Italy.

Pancreas
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

CA19-9 blood tests show good sensitivity for diagnosing advanced pancreatic cancer in Italy. However, their diagnostic value is limited for early-stage pancreatic cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcoholic pancreatitis: new pathogenetic insights.

Minerva medica·2008
Same author

Benign pancreatic hyperenzymemia or Gullo's syndrome.

Advances in medical sciences·2008
Same author

Familial association of benign pancreatic hyperenzymaemia and pancreatic cancer.

Gut·2007
Same author

Benign pancreatic hyperenzymemia.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2007
Same author

The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005
Same author

Quality of life in patients with chronic pancreatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005
Same journal

Outcomes of Surveillance Program for Individuals at High-Risk of Pancreatic Adenocarcinoma.

Pancreas·2026
Same journal

ITGB4 Activates the Pentose Phosphate Pathway to Reduce the Sensitivity of Pancreatic Adenocarcinoma to Gemcitabine.

Pancreas·2026
Same journal

AI-driven Test-Free Prediction of ICU Admission, Insulin Dependence, and Exocrine Dysfunction after Acute Pancreatitis.

Pancreas·2026
Same journal

Redefining Prognosis in Acute Pancreatitis: The Emerging Role of Antioxidant Biomarkers.

Pancreas·2026
Same journal

Commentary on "High Rate of Exocrine Pancreatic Dysfunction in Pediatric Patients with Diabetes Mellitus".

Pancreas·2026
Same journal

Pancreatic Ductal Adenocarcinoma (PDAC) Arising from Mixed Duct Intraductal Papillary Mucinous Neoplasm (IPMN) can Mimic Multifocal Pseudocyst.

Pancreas·2026
See all related articles

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Pancreatic cancer diagnosis relies on various markers.
  • CA19-9 is a commonly used serum tumor marker.

Purpose of the Study:

  • To review the diagnostic utility of CA19-9 in Italian studies for pancreatic cancer.
  • To compare CA19-9's accuracy against other available serum tumor markers.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of diagnostic performance data from Italian studies.

Main Results:

  • CA19-9 determination demonstrates high sensitivity for advanced pancreatic cancer.
  • Diagnostic accuracy of CA19-9 surpasses other current serum tumor markers.
  • Limited data suggests low diagnostic value for early pancreatic cancer.

Related Experiment Videos

Conclusions:

  • CA19-9 is a valuable marker for advanced pancreatic cancer diagnosis in Italy.
  • Further research is needed to clarify CA19-9's role in early pancreatic cancer detection.